Atlas Copco AB
ATCO-B.ST · STO
Analyst ratings
hold · 0 ratings
| Date | Firm | Action | Rating | Price target |
|---|
Earnings growth expectations: Realistic or overly optimistic?
Atlas Copco's earnings are projected to grow 16.67% in the coming year, supported by record-breaking order intake up 27% to SEK 51bn and a 60% surge in Vacuum Technique. Multiple analysts from JP Morgan, Citigroup, and Handelsbanken have raised price targets, reflecting strong confidence in the company's near-term profit trajectory.
Consensus expectations of 9–11% adjusted EPS growth are viewed as unrealistic in light of recent double-digit earnings declines. The projected recovery appears to be priced in prematurely, and current forecasts may not adequately reflect ongoing cyclical headwinds facing the industrial machinery sector.
Valuation premium: Justified by fundamentals or a red flag?
Trading at 25 times expected operating profit — below its historical average — Atlas Copco is considered a bargain by Dagens industri. With Vacuum Technique accelerating and compressor and industrial tool cycles set to recover, the current valuation is seen as an attractive entry point relative to long-term growth potential.
Despite trading at a slight discount to historical norms, Atlas Copco's premium valuation remains difficult to justify given the lack of consistent earnings growth. A Hold rating has been assigned, with the view that the stock's current price already reflects an overly optimistic scenario that earnings may not deliver.
Technical momentum: Recovery signal or sustained downtrend?
A buy signal was issued from a pivot bottom on July 18, 2025, with the stock rising 2.77% since then. Support from accumulated volume at kr134.45 provides a potential buying opportunity, and the stock's controlled movements and high liquidity suggest low overall trading risk for near-term investors.
Atlas Copco holds sell signals from both short- and long-term moving averages, with the long-term average sitting above the short-term average — a classically negative crossover. A sell signal from the 3-month MACD further reinforces the view that the stock is likely to continue underperforming in the near term.